We are live on ! Find out more
LA

Lifeworks Advisors Portfolio holdings

AUM $779M
1-Year Est. Return 21.25%
This Fund
S&P 500
This Quarter Est. Return
-11.47%
1 Year Est. Return
+21.25%
3 Year Est. Return
+53.77%
5 Year Est. Return
10 Year Est. Return
AUM
$158M
AUM Growth
+$6.31M
Cap. Flow
+$70.6M
Cap. Flow %
44.73%
Top 10 Hldgs %
28.32%
Holding
151
New
24
Increased
86
Reduced
24
Closed
9

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$1.32M
2
TRMB icon
Trimble
TRMB
+$745K
3
EMN icon
Eastman Chemical
EMN
+$714K
4
EBAY icon
eBay
EBAY
+$437K
5
LNT icon
Alliant Energy
LNT
+$285K

Sector Composition

Rank Sector Weight
1 Technology 26.65%
2 Healthcare 25.69%
3 Consumer Staples 6.18%
4 Industrials 5.77%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUNZ icon
1
VanEck Merk Gold Trust
OUNZ
$2.53B
$6.08M 3.86%
347,106
+21,684
+7% +$394K
FHLC icon
2
Fidelity MSCI Health Care Index ETF
FHLC
$3.31B
$6M 3.81%
98,950
+14,516
+17% +$901K
FTEC icon
3
Fidelity MSCI Information Technology Index ETF
FTEC
$19.6B
$5.96M 3.78%
61,714
+2,647
+4% +$282K
JNJ icon
4
Johnson & Johnson
JNJ
$645B
$4.6M 2.92%
25,918
+1,836
+8% +$327K
MSFT icon
5
Microsoft
MSFT
$2.9T
$4.5M 2.85%
17,502
+1,347
+8% +$366K
AAPL icon
6
Apple
AAPL
$4.95T
$3.9M 2.48%
28,555
-207
-0.7% -$31.3K
ABBV icon
7
AbbVie
ABBV
$459B
$3.7M 2.34%
24,139
+2,504
+12% +$383K
MRK icon
8
Merck
MRK
$326B
$3.4M 2.16%
37,292
+608
+2% +$53.9K
SCHO icon
9
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$3.34M 2.12%
135,970
+380
+0.3% +$9.37K
LLY icon
10
Eli Lilly
LLY
$1.07T
$3.19M 2.02%
9,850
-633
-6% -$190K
GILD icon
11
Gilead Sciences
GILD
$163B
$3.19M 2.02%
51,543
+46,437
+909% +$2.88M
PFE icon
12
Pfizer
PFE
$141B
$3.18M 2.02%
60,703
+5,454
+10% +$278K
SPY icon
13
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$3.11M 1.97%
113,474
+109,171
+2,537% +$44.7M
ORCL icon
14
Oracle
ORCL
$344B
$2.85M 1.81%
40,863
+6,995
+21% +$512K
CSCO icon
15
Cisco
CSCO
$448B
$2.83M 1.8%
66,430
+13,952
+27% +$668K
AMGN icon
16
Amgen
AMGN
$204B
$2.8M 1.77%
11,506
+846
+8% +$207K
BIIB icon
17
Biogen
BIIB
$29.9B
$2.75M 1.74%
13,491
+1,256
+10% +$257K
ICE icon
18
Intercontinental Exchange
ICE
$83.6B
$2.56M 1.63%
27,269
+7,440
+38% +$795K
MSI icon
19
Motorola Solutions
MSI
$70.8B
$2.42M 1.53%
11,534
+2,039
+21% +$445K
REGN icon
20
Regeneron Pharmaceuticals
REGN
$70.9B
$2.24M 1.42%
+3,787
New +$2.46M
ABT icon
21
Abbott
ABT
$183B
$2.23M 1.41%
20,519
+4,507
+28% +$512K
BIO icon
22
Bio-Rad Laboratories Class A
BIO
$8.5B
$2.07M 1.31%
4,173
-295
-7% -$154K
QCOM icon
23
Qualcomm
QCOM
$177B
$2.01M 1.27%
15,721
+3,346
+27% +$454K
IBM icon
24
IBM
IBM
$204B
$1.96M 1.24%
13,854
+3,615
+35% +$488K
INTC icon
25
Intel
INTC
$454B
$1.92M 1.22%
51,350
+9,199
+22% +$398K

Similar funds

Lifeworks Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Lifeworks Advisors held 151 positions worth $158M, up 4.2% from $151M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Lifeworks Advisors deployed $70.6M of net new capital in Q2 2022, opening 24 new positions and adding to 86 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 3,787 shares worth $2.24M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was eBay, an estimated $437K trimmed.

  • Lifeworks Advisors's largest Q2 2022 buy was Regeneron Pharmaceuticals: 3,787 shares worth $2.24M.
  • Lifeworks Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $44.7M increase.
  • Lifeworks Advisors's biggest Q2 2022 reduction was eBay, cutting an estimated $437K.
  • Lifeworks Advisors fully exited Zebra Technologies in Q2 2022, selling an estimated $1.32M.
  • Lifeworks Advisors's ten largest holdings make up 28% of its $158M portfolio in Q2 2022.
  • Lifeworks Advisors opened 24 new positions and closed 9 in Q2 2022.
  • Lifeworks Advisors's portfolio value rose 4.2% quarter-over-quarter to $158M.

Based on Lifeworks Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.